Friocruz, AstraZeneca ink deal to import API in 2022

Brazil’s Oswaldo Cruz Foundation (Fiocruz) and pharmaceutical company AstraZeneca signed an agreement for the purchase of the active pharmaceutical ingredient (API). The new batches of the API will make it possible for Fiocruz’s Rio-based Immuno-biological Technology Institute (Bio-Manguinhos) to manufacture 60 million doses of the vaccine against COVID-19 in 2022. The deal is expected to […]

Fonte